Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liangping Xia

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 4, 2017
The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric CancerPengfei Kong, Xiaofeng Zhu, Qirong Geng, et al.
Cell Death & Disease|August 8, 2024
ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNAYanan Jin, Jijin Yao, Jianchang Fu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 4, 2019
An exploratory study of CT-guided percutaneous radiofrequency ablation for stage I thymomaJun Dong, Shaofei Yuan, Boyang Chang, et al.
Journal for Immunotherapy of Cancer|November 9, 2021
PD-1/PD-L1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in first-line treatment for non-squamous non-small-cell lung cancerHui Yu, Ping Chen, Liangping Xia, et al.
Journal of Cancer|November 22, 2017
Association between Mismatch-repair Genetic variation and the Risk of Multiple Primary Cancers: A Meta-AnalysisPengfei Kong, Ruiyan Wu, Yadong Lan, et al.
Journal of Cancer|October 5, 2016
The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal CancerChenxi Yin, Gang Ma, Yuming Rong, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 5, 2024
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpressionKunwei Peng, Yongxiang Liu, Shousheng Liu, et al.
Journal of Cancer|June 18, 2019
Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene StatusPengfei Kong, Jing Wang, Ze Song, et al.
Aging|December 31, 2018
Comparisons of metastatic patterns of colorectal cancer among patients by age group: a population-based studyLin Yang, Xingli Yang, Wenzhuo He, et al.
Medical Oncology (Northwood, London, England)|January 12, 2013
Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancerWenzhuo He, Chenxi Yin, Guifang Guo, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 4, 2017
The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric CancerPengfei Kong, Xiaofeng Zhu, Qirong Geng, et al.
Cell Death & Disease|August 8, 2024
ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNAYanan Jin, Jijin Yao, Jianchang Fu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 4, 2019
An exploratory study of CT-guided percutaneous radiofrequency ablation for stage I thymomaJun Dong, Shaofei Yuan, Boyang Chang, et al.
Journal for Immunotherapy of Cancer|November 9, 2021
PD-1/PD-L1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in first-line treatment for non-squamous non-small-cell lung cancerHui Yu, Ping Chen, Liangping Xia, et al.
Journal of Cancer|November 22, 2017
Association between Mismatch-repair Genetic variation and the Risk of Multiple Primary Cancers: A Meta-AnalysisPengfei Kong, Ruiyan Wu, Yadong Lan, et al.
Journal of Cancer|October 5, 2016
The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal CancerChenxi Yin, Gang Ma, Yuming Rong, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 5, 2024
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpressionKunwei Peng, Yongxiang Liu, Shousheng Liu, et al.
Journal of Cancer|June 18, 2019
Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene StatusPengfei Kong, Jing Wang, Ze Song, et al.
Aging|December 31, 2018
Comparisons of metastatic patterns of colorectal cancer among patients by age group: a population-based studyLin Yang, Xingli Yang, Wenzhuo He, et al.
Medical Oncology (Northwood, London, England)|January 12, 2013
Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancerWenzhuo He, Chenxi Yin, Guifang Guo, et al.
Pageof 9